Page 4 - Device Program News Today

LDGraft is a next-generation bone graft substitute for spinal fusion, with uniquely encapsulated rhBMP-2 for controlled and extended-release Seeking to target significant and growing chronic low

Conference call to discuss financial and operational results scheduled for Thursday, March 16, at 8:30 a.m. U.S. Eastern Time Executed global licensing and...

Dr. Valluvan Jeevanandam and Dr. Christopher Salerno spoke to The Maroon about UChicago Medicine’s record-setting numbers.

UChicago Medicine, which is pushing further into the Northwest Indiana market with a micro-hospital in Crown Point, did 66 heart transplants last year.

GOTHENBURG, SE / ACCESSWIRE / September 20, 2022 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) XVIVO has been granted Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA)

Companies often come to us when they feel that they are ready to submit their medical device to the FDA for clearance or approval, but Medical Technology newcomers may not realize the...

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Boston, MA (PRWEB) February 22, 2022 -- DynamiCare Health Inc., a digital therapeutics and telehealth company dedicated to helping people overcome addiction,

Comaneci temporarily expands blood vessels-recognized as novel device for life-threatening disease Rapid Medical, a leading developer of advanced neurovascular devices, today announced FDA breakthrough

Geneva, ILLINOIS (PRWEB) November 30, 2021 -- Argentum Medical, a medical device leader and pioneer of silver- plated nylon technology, today announced the